Back to News
Market Impact: 0.22
Elutia Receives $8 Million Payment from Boston Scientific; Company Now Fully Funded into 2029
Source: GlobeNewswire
M&A & RestructuringCompany FundamentalsHealthcare & Biotech
Elutia received the full $8 million previously held in escrow from the sale of its BioEnvelope business to Boston Scientific. The escrow release provides incremental cash proceeds and confirms completion of this aspect of the divestiture, modestly strengthening Elutia's financial position.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.35
Ticker Sentiment
BSX-0.05
ELUT0.75
More News
- Elutia receives $8 million escrow from Boston Scientific sale
- $8.2B acquisition validates AI-picked chip stock: +20% since June
- Nike Warns Sales Slump Will Worsen This Fiscal Year
- Nuveen CEO on Schroders Deal, Plans for Combined Company
- Broadcom to lend Anthropic up to $42 billion to lease its chips, filing says
- New Mexico wants Meta to pay up to $40 billion in penalties after data privacy trial
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Weekly Update: Advanced Search Filters, Redesigned Ticker Dashboard, and Improved Search Experience
- How to Build an Automated Research Process for a Fund